SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-054080
Filing Date
2017-02-23
Accepted
2017-02-23 16:34:03
Documents
3
Period of Report
2017-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d343414d8k.htm 8-K 15998
2 EX-99.1 d343414dex991.htm EX-99.1 78368
3 GRAPHIC g343414g0223203541548.jpg GRAPHIC 3344
  Complete submission text file 0001193125-17-054080.txt   100222
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 17633012
SIC: 2834 Pharmaceutical Preparations